Name
TAMRO EESTI OÜ
Registry code
10173188
VAT number
EE100075223
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
11.12.1996 (27)
Financial year
01.02-31.01
Capital
351 514.00 €
Activity
46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Katrin Altmets 11.02.1970 (54) | - | Procurator | - | |
| Rainer Kaseväli 06.08.1980 (44) | - | Procurator | - | |
| Krister Tamm 30.12.1980 (43) | - | Board member | - | |
| Leon Jankelevitsh 09.03.1975 (49) | - | Board member | - | |
| Tanel Kuusmann 15.07.1977 (47) | - | Board member | - |
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| BENU Eesti OÜ 16131721 | 100% - 2 500.00 EUR | - | - |
| 2019 05.10.2020 | 2020 09.07.2021 | 2021 13.07.2022 | 2022 26.07.2023 | |
|---|---|---|---|---|
| Total Revenue | 138 208 000 € | - | - | - |
| Net profit (loss) for the period | 2 642 000 € | - | - | - |
| Profit Margin | 2% | - | - | - |
| Current Assets | 51 494 000 € | - | - | - |
| Fixed Assets | 11 383 000 € | - | - | - |
| Total Assets | 62 877 000 € | - | - | - |
| Current Liabilities | 32 311 000 € | - | - | - |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 30 566 000 € | - | - | - |
| Employees | 103 | - | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 85 874 283.34 € | 3 658 464.56 € | 800 918.12 € | 182 |
| 2023 Q4 | 93 231 161.05 € | 4 222 844.22 € | 839 224.03 € | 181 |
| 2023 Q3 | 83 151 599.99 € | 4 442 722.92 € | 761 533.37 € | 176 |
| 2023 Q2 | 87 582 129.72 € | 4 520 629.8 € | 1 285 371.23 € | 186 |
| 2023 Q1 | 85 056 754.54 € | 3 757 492.34 € | 767 593.34 € | 183 |
| 2022 Q4 | 84 792 908.2 € | 3 906 891.35 € | 751 425.6 € | 180 |
| 2022 Q3 | 79 185 942.59 € | 4 307 011.42 € | 664 727.81 € | 184 |
| 2022 Q2 | 85 494 297.88 € | 4 218 917.98 € | 1 163 481.38 € | 185 |
| 2022 Q1 | 76 219 938.98 € | 3 427 586.55 € | 598 377.52 € | 175 |
| 2021 Q4 | 80 486 979.85 € | 3 754 285.37 € | 607 877.62 € | 175 |
| 2021 Q3 | 67 278 616.18 € | 3 173 048.43 € | 574 710.25 € | 161 |
| 2021 Q2 | 70 143 682.38 € | 3 953 083.2 € | 967 135.05 € | 166 |
| 2021 Q1 | 64 160 903.49 € | 2 516 337.4 € | 470 777.18 € | 159 |
| 2020 Q4 | 65 902 805.96 € | 2 930 498.19 € | 412 706.7 € | 141 |
| 2020 Q3 | 56 785 264.99 € | 2 530 583.07 € | 428 455.88 € | 135 |
| 2020 Q2 | 70 445 664.81 € | 3 584 495.2 € | 589 405.41 € | 140 |
| 2020 Q1 | 64 553 183.68 € | 2 574 773.77 € | 376 784.71 € | 138 |
